Prioritising patients back to work: a small step for NICE, a giant leap for the NHS

Abstract

Announcing investments in a five year trial ­­­­­­of tirzepatide (a glucagon-like peptide-1 analogue weight loss drug), health secretary Wes Streeting showed support for prioritising patients able to return to work, saying that obesity was not only a health issue but also “holding back our economy.”12 Incorporating the economic benefits of returning people to work sooner echoes concerns raised in the Darzi report, commissioned by Streeting. …